Empfehlung
34,5
Verkaufen
Composite Score (0–100)
Insider (25%)
22
1 Insider, 12K $ Volumen
Institutionell (22,5%)
65.8
77 neu, 205 erhöht, -963653K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | QUEST DIAGNOSTICS INC |
|---|---|
| Ticker | DGX |
| CIK | 0001022079 |
Branche
| SIC-Code | 8071 |
|---|---|
| Beschreibung | Services-Medical Laboratories |
Wertpapier
| CUSIP | 74834l100 |
|---|---|
| ISIN | US74834L1008 |
| Typ | Common Stock |
| Titel | QUEST DIAGNOSTICS INC |
Status
| Zuletzt geprüft | 2026-03-20 22:39:20.350657 |
|---|
Fondsaktivität (letzte 3 Quartale)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 14,392,082 | 14,251,632 | 140,450 | 2,497,458,052 | Aufgestockt | +1,0% | |
| BlackRock, Inc. | 9,459,218 | 10,002,035 | -542,817 | 1,641,458,028 | Reduziert | -5,4% | |
| STATE STREET CORP | 5,382,547 | 5,223,930 | 158,617 | 934,033,381 | Aufgestockt | +3,0% | |
| JPMORGAN CHASE & CO | 4,145,896 | 4,326,991 | -181,095 | 719,437,502 | Reduziert | -4,2% | |
| Boston Partners | 3,913,326 | 4,036,881 | -123,555 | 680,020,198 | Reduziert | -3,1% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3,028,207 | 3,036,485 | -8,278 | 523,515,466 | Reduziert | -0,3% | |
| MORGAN STANLEY | 2,693,568 | 2,286,910 | 406,658 | 467,415,402 | Aufgestockt | +17,8% | |
| VICTORY CAPITAL MANAGEMENT INC | 2,126,422 | 2,343,974 | -217,552 | 368,998,036 | Reduziert | -9,3% | |
| DIMENSIONAL FUND ADVISORS LP | 1,931,548 | 1,907,510 | 24,038 | 335,203,671 | Aufgestockt | +1,3% | |
| WELLS FARGO & COMPANY/MN | 1,769,093 | 1,825,394 | -56,301 | 306,990,631 | Reduziert | -3,1% | |
| GOLDMAN SACHS GROUP INC | 1,762,663 | 1,063,716 | 698,947 | 305,874,991 | Aufgestockt | +65,7% | |
| Invesco Ltd. | 1,666,979 | 1,688,769 | -21,790 | 289,270,867 | Reduziert | -1,3% | |
| EdgePoint Investment Group Inc. | 1,661,072 | 849,752 | 811,320 | 288,245,824 | Aufgestockt | +95,5% | |
| BANK OF AMERICA CORP /DE/ | 1,622,938 | 1,635,075 | -12,137 | 281,628,383 | Reduziert | -0,7% | |
| DAVIS SELECTED ADVISERS | 1,589,883 | 1,361,612 | 228,271 | 275,895,498 | Aufgestockt | +16,8% | |
| NORGES BANK | 1,322,663 | 1,325,624 | -2,961 | 229,521,710 | Reduziert | -0,2% | |
| FMR LLC | 1,202,254 | 1,213,372 | -11,118 | 208,627,187 | Reduziert | -0,9% | |
| UBS Group AG | 1,114,451 | 664,290 | 450,161 | 193,390,683 | Aufgestockt | +67,8% | |
| NORTHERN TRUST CORP | 1,078,573 | 1,153,325 | -74,752 | 187,164,772 | Reduziert | -6,5% | |
| FIDUCIARY MANAGEMENT INC /WI/ | 1,046,921 | 1,147,534 | -100,613 | 181,672,201 | Reduziert | -8,8% | |
| AMERICAN CENTURY COMPANIES INC | 870,500 | 869,085 | 1,415 | 151,058,412 | Aufgestockt | +0,2% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 846,935 | 0 | 846,935 | 146,968,630 | Neu | +100,0% | |
| Legal & General Group Plc | 742,974 | 755,675 | -12,701 | 128,928,276 | Reduziert | -1,7% | |
| Qube Research & Technologies Ltd | 733,456 | 529,800 | 203,656 | 127,276,620 | Aufgestockt | +38,4% | |
| ALLIANCEBERNSTEIN L.P. | 632,407 | 634,773 | -2,366 | 109,741,587 | Reduziert | -0,4% | |
| DEUTSCHE BANK AG\ | 609,081 | 524,146 | 84,935 | 105,693,826 | Aufgestockt | +16,2% | |
| Squarepoint Ops LLC | 575,900 | 638,492 | -62,592 | 99,935,927 | Reduziert | -9,8% | |
| PRINCIPAL FINANCIAL GROUP INC | 531,286 | 534,470 | -3,184 | 92,196,063 | Reduziert | -0,6% | |
| RAYMOND JAMES FINANCIAL INC | 463,282 | 458,037 | 5,245 | 80,393,391 | Aufgestockt | +1,1% | |
| Artemis Investment Management LLP | 460,725 | 431,641 | 29,084 | 79,949,609 | Aufgestockt | +6,7% | |
| JANE STREET GROUP, LLC | 402,034 | 164,957 | 237,077 | 69,764,960 | Aufgestockt | +143,7% | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 350,249 | 338,981 | 11,268 | 60,778,709 | Aufgestockt | +3,3% | |
| BARCLAYS PLC | 333,302 | 298,922 | 34,380 | 57,837,898 | Aufgestockt | +11,5% | |
| CITIGROUP INC | 309,817 | 319,354 | -9,537 | 53,762,459 | Reduziert | -3,0% | |
| Swiss National Bank | 306,500 | 321,800 | -15,300 | 53,186,945 | Reduziert | -4,8% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 299,628 | 493,032 | -193,404 | 51,994,447 | Reduziert | -39,2% | |
| RHUMBLINE ADVISERS | 276,463 | 274,446 | 2,017 | 47,974,507 | Aufgestockt | +0,7% | |
| RTW INVESTMENTS, LP | 250,000 | 500,000 | -250,000 | 47,645,000 | Reduziert | -50,0% | |
| Quantinno Capital Management LP | 269,597 | 193,514 | 76,083 | 46,783,330 | Aufgestockt | +39,3% | |
| BNP PARIBAS FINANCIAL MARKETS | 228,057 | 221,570 | 6,487 | 39,574,731 | Aufgestockt | +2,9% | |
| HSBC HOLDINGS PLC | 227,107 | 212,746 | 14,361 | 39,488,131 | Aufgestockt | +6,8% | |
| BANK OF MONTREAL /CAN/ | 217,384 | 202,602 | 14,782 | 37,722,720 | Aufgestockt | +7,3% | |
| BAHL & GAYNOR INC | 187,288 | 216,704 | -29,416 | 32,500,087 | Reduziert | -13,6% | |
| 8 KNOTS MANAGEMENT, LLC | 176,538 | 0 | 176,538 | 31,711,521 | Neu | +100,0% | |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 174,290 | 0 | 174,290 | 31,307,713 | Neu | +100,0% | |
| SOUTH PLAINS FINANCIAL, INC. | 178 | 178 | 0 | 30,888,000 | Unverändert | 0,0% | |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 175,146 | 341,653 | -166,507 | 30,393,085 | Reduziert | -48,7% | |
| CONNING INC. | 173,262 | 0 | 173,262 | 30,066,156 | Neu | +100,0% | |
| ANTIPODES PARTNERS Ltd | 171,987 | 61,707 | 110,280 | 29,847,142 | Aufgestockt | +178,7% | |
| APG Asset Management N.V. | 197,892 | 212,972 | -15,080 | 29,239,388 | Reduziert | -7,1% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-05 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -3,878 | 206.21 | -799,682.38 | -129,9% | |
| 2026-03-05 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -5,558 | 206.21 | -1,146,115.18 | -186,2% | |
| 2026-03-05 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -2,855 | 206.21 | -588,729.55 | -95,6% | |
| 2026-03-04 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Open Market Sale | -2,628 | 204.86 | -538,372.08 | -87,5% | |
| 2026-03-03 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -526 | 207.73 | -109,265.98 | -17,8% | |
| 2026-03-03 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -632 | 207.73 | -131,285.36 | -21,3% | |
| 2026-03-03 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -410 | 207.73 | -85,169.30 | -13,8% | |
| 2026-03-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -10,000 | 212.52 | -2,125,200.00 | -345,3% | |
| 2026-02-19 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -1,433 | 204.83 | -293,521.39 | -47,7% | |
| 2026-02-19 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -958 | 204.83 | -196,227.14 | -31,9% | |
| 2026-02-19 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -1,111 | 204.83 | -227,566.13 | -37,0% | |
| 2026-02-13 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -1,619 | 208.21 | -337,093.12 | -54,8% | |
| 2026-02-13 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -351 | 209.10 | -73,394.94 | -11,9% | |
| 2026-02-13 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -3,500 | 207.08 | -724,787.70 | -117,7% | |
| 2026-02-13 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -10,122 | 206.37 | -2,088,883.21 | -339,4% | |
| 2026-02-13 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -10,573 | 205.21 | -2,169,655.73 | -352,5% | |
| 2026-02-10 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -5,662 | 204.00 | -1,155,048.00 | -187,6% | |
| 2026-01-28 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Small Acquisition | 16 | 183.52 | 2,936.26 | +0,5% | |
| 2026-01-28 | Gregg Vicky B | Director | Small Acquisition | 67 | 183.51 | 12,295.37 | +2,0% | |
| 2026-01-28 | CARTER ROBERT B | Director | Small Acquisition | 6 | 183.51 | 1,101.06 | +0,2% | |
| 2026-01-28 | DELANEY MARK E | Officer, SVP & Chief Commercial Officer | Small Acquisition | 15 | 183.51 | 2,752.65 | +0,4% | |
| 2026-01-28 | Lassiter Wright III | Director | Small Acquisition | 7 | 183.51 | 1,284.57 | +0,2% | |
| 2025-11-25 | Gregg Vicky B | Director | Open Market Sale | -1,250 | 191.76 | -239,700.00 | -38,9% | |
| 2025-11-25 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -4,747 | 192.97 | -916,036.66 | -148,8% | |
| 2025-11-25 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -41,004 | 192.27 | -7,883,900.59 | -1280,8% | |
| 2025-11-25 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -9,342 | 191.59 | -1,789,822.57 | -290,8% | |
| 2025-11-18 | DELANEY MARK E | Officer, SVP & Chief Commercial Officer | Open Market Sale | -7,946 | 187.35 | -1,488,683.10 | -241,9% | |
| 2025-10-22 | PFEIFFER GARY M | Director | Open Market Sale | -1,482 | 182.40 | -270,316.80 | -43,9% | |
| 2025-09-26 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -144 | 188.66 | -27,166.77 | -4,4% | |
| 2025-09-26 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -83 | 187.22 | -15,539.24 | -2,5% | |
| 2025-09-24 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -175 | 187.02 | -32,729.03 | -5,3% | |
| 2025-09-23 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -28,288 | 187.12 | -5,293,312.79 | -860,0% | |
| 2025-08-21 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -1,975 | 185.00 | -365,375.00 | -59,4% | |
| 2025-08-19 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -4,532 | 183.00 | -829,356.00 | -134,7% | |
| 2025-08-15 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -1,975 | 180.00 | -355,500.00 | -57,8% | |
| 2025-08-06 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -1,975 | 175.00 | -345,625.00 | -56,2% | |
| 2025-08-06 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -3,560 | 175.00 | -623,000.00 | -101,2% | |
| 2025-07-31 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Open Market Sale | -2,210 | 170.00 | -375,700.00 | -61,0% | |
| 2025-07-30 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Open Market Sale | -5,224 | 167.40 | -874,497.60 | -142,1% | |
| 2025-07-30 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Open Market Sale | -3,045 | 167.40 | -509,733.00 | -82,8% | |
| 2025-07-21 | SAMAD SAM | Officer, Executive Vice President & CFO | Small Acquisition | 72 | 167.50 | 12,059.71 | +2,0% | |
| 2025-07-21 | Plewman Patrick | Officer, SVP for Diagnostic Services | Small Acquisition | 80 | 167.49 | 13,399.52 | +2,2% | |
| 2025-07-21 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Small Acquisition | 27 | 167.50 | 4,522.45 | +0,7% | |
| 2025-07-21 | Lassiter Wright III | Director | Small Acquisition | 7 | 167.51 | 1,172.54 | +0,2% | |
| 2025-07-21 | Gregg Vicky B | Director | Small Acquisition | 79 | 167.50 | 13,232.11 | +2,1% | |
| 2025-07-21 | DELANEY MARK E | Officer, SVP & Chief Commercial Officer | Small Acquisition | 17 | 167.49 | 2,847.35 | +0,5% | |
| 2025-07-21 | CARTER ROBERT B | Director | Small Acquisition | 7 | 167.51 | 1,172.54 | +0,2% | |
| 2025-05-13 | DELANEY MARK E | Officer, SVP & Chief Commercial Officer | Open Market Sale | -874 | 175.31 | -153,220.94 | -24,9% | |
| 2025-05-12 | DELANEY MARK E | Officer, SVP & Chief Commercial Officer | Open Market Sale | -874 | 175.72 | -153,579.28 | -25,0% | |
| 2025-04-21 | SAMAD SAM | Officer, Executive Vice President & CFO | Small Acquisition | 74 | 164.42 | 12,167.23 | +2,0% | |
| 2025-04-21 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Small Acquisition | 27 | 164.42 | 4,439.39 | +0,7% | |
| 2025-04-21 | Plewman Patrick | Officer, SVP for Diagnostic Services | Small Acquisition | 81 | 164.42 | 13,318.26 | +2,2% | |
| 2025-04-21 | DELANEY MARK E | Officer, SVP & Chief Commercial Officer | Small Acquisition | 25 | 164.42 | 4,110.53 | +0,7% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -453 | 169.63 | -76,844.20 | -12,5% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -902 | 168.79 | -152,249.48 | -24,7% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -1,493 | 167.88 | -250,642.75 | -40,7% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -267 | 169.60 | -45,282.45 | -7,4% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -584 | 168.70 | -98,520.27 | -16,0% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -750 | 167.86 | -125,897.10 | -20,5% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -2,493 | 169.57 | -422,736.02 | -68,7% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -5,900 | 168.66 | -995,120.55 | -161,7% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -6,950 | 167.86 | -1,166,627.00 | -189,5% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -2,764 | 169.56 | -468,662.46 | -76,1% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -4,905 | 168.72 | -827,563.75 | -134,4% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -7,249 | 167.86 | -1,216,844.69 | -197,7% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -704 | 169.63 | -119,416.49 | -19,4% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -1,411 | 168.76 | -238,114.01 | -38,7% | |
| 2025-04-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -2,366 | 168.03 | -397,553.07 | -64,6% | |
| 2025-04-02 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Open Market Sale | -2,555 | 170.00 | -434,350.00 | -70,6% |
Top-Fondshalter (aktuelles Quartal)
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| VANGUARD GROUP INC | 14,392,082 | 2,497,458,052 | 17.61 |
| BlackRock, Inc. | 9,459,218 | 1,641,458,028 | 11.57 |
| STATE STREET CORP | 5,382,547 | 934,033,381 | 6.59 |
| JPMORGAN CHASE & CO | 4,145,896 | 719,437,502 | 5.07 |
| Boston Partners | 3,913,326 | 680,020,198 | 4.79 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,028,207 | 523,515,466 | 3.69 |
| MORGAN STANLEY | 2,693,568 | 467,415,402 | 3.30 |
| VICTORY CAPITAL MANAGEMENT INC | 2,126,422 | 368,998,036 | 2.60 |
| DIMENSIONAL FUND ADVISORS LP | 1,931,548 | 335,203,671 | 2.36 |
| WELLS FARGO & COMPANY/MN | 1,769,093 | 306,990,631 | 2.16 |
| GOLDMAN SACHS GROUP INC | 1,762,663 | 305,874,991 | 2.16 |
| Invesco Ltd. | 1,666,979 | 289,270,867 | 2.04 |
| EdgePoint Investment Group Inc. | 1,661,072 | 288,245,824 | 2.03 |
| BANK OF AMERICA CORP /DE/ | 1,622,938 | 281,628,383 | 1.99 |
| DAVIS SELECTED ADVISERS | 1,589,883 | 275,895,498 | 1.95 |
| NORGES BANK | 1,322,663 | 229,521,710 | 1.62 |
| FMR LLC | 1,202,254 | 208,627,187 | 1.47 |
| UBS Group AG | 1,114,451 | 193,390,683 | 1.36 |
| NORTHERN TRUST CORP | 1,078,573 | 187,164,772 | 1.32 |
| FIDUCIARY MANAGEMENT INC /WI/ | 1,046,921 | 181,672,201 | 1.28 |